Physician profile
Amy Odom
NPI 1750863726
$1,219.47
in general payments reported to CMS, 2019-2025
16 companies · $655 in 2025
The $655 reported for 2025 was more than what 78% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.76 · 2022: $87.49 · 2023: $71.50 · 2024: $335 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $191.35 | 2021-2025 | Breztri, Tezspire, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $166.02 | 2021-2025 | Ofev, Jascayd |
| Glaxosmithkline, LLC. | $148.02 | 2023-2025 | Trelegy Ellipta, Nucala |
| Abbvie INC. | $132.66 | 2022-2024 | |
| Jazz Pharmaceuticals INC. | $126.76 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.89 | 2024-2025 | Glassia |
| Mallinckrodt Hospital Products INC. | $79.84 | 2024-2025 | Acthar |
| Viatris Specialty LLC | $50.18 | 2025 | Yupelri |
| Mylan Specialty L.P. | $41.14 | 2024 | Yupelri |
| Bausch Health US, LLC | $40.01 | 2022 | |
| Grifols USA, LLC | $30.53 | 2025 | Prolastin-C Liquid |
| Genzyme Corporation | $20.55 | 2025 | |
| Verona Pharma, INC. | $19.81 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $18.91 | 2025 | Dupixent |
| Axsome Therapeutics, INC. | $17.97 | 2025 | Sunosi |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $17.83 | 2025 | Tyvaso |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Odom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.